Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs SentinelOne Inc. Class A Common Stock (S) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs SentinelOne Inc. Class A Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while SentinelOne Inc. Class A Common Stock trades at $26.28 (market cap $8.84B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and SentinelOne Inc. Class A Common Stock is trading nearer its 52-week high, Halozyme Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and SentinelOne Inc. Class A Common Stock for 1 Days on average.
| HALO | S | |
|---|---|---|
Market Cap | $12.58B | $8.84B |
Volume | 2,179,278 | 7,515,091 |
Sector | Health | Technology |
52-Week High | $115.22 | $25.80 |
52-Week Low | $61.63 | $11.94 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $8.23B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About SentinelOne Inc. Class A Common Stock
SentinelOne provides an AI-powered cybersecurity platform for organizations. Its Singularity platform helps detect, prevent, and respond to threats across endpoints, cloud workloads, identities, and connected devices.
Read more on S →
